203 related articles for article (PubMed ID: 35383082)
1. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.
Goldfarb DM; Mâsse LC; Watts AW; Hutchison SM; Muttucomaroe L; Bosman ES; Barakauskas VE; Choi A; Dhillon N; Irvine MA; Reicherz F; O'Reilly C; Sediqi S; Xu RY; Razzaghian HR; Sadarangani M; Coombs D; O'Brien SF; Lavoie PM
BMJ Open; 2022 Apr; 12(4):e057846. PubMed ID: 35383082
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada.
Watts AW; Mâsse LC; Goldfarb DM; Irvine MA; Hutchison SM; Muttucomaroe L; Poon B; Barakauskas VE; O'Reilly C; Bosman E; Reicherz F; Coombs D; Pitblado M; O'Brien SF; Lavoie PM
BMJ Open; 2023 Jun; 13(6):e071228. PubMed ID: 37308276
[TBL] [Abstract][Full Text] [Related]
3. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
5. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
medRxiv; 2020 Oct; ():. PubMed ID: 33140066
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a Program for SARS-CoV-2 Screening and Environmental Monitoring in an Urban Public School District.
Crowe J; Schnaubelt AT; SchmidtBonne S; Angell K; Bai J; Eske T; Nicklin M; Pratt C; White B; Crotts-Hannibal B; Staffend N; Herrera V; Cobb J; Conner J; Carstens J; Tempero J; Bouda L; Ray M; Lawler JV; Campbell WS; Lowe JM; Santarpia J; Bartelt-Hunt S; Wiley M; Brett-Major D; Logan C; Broadhurst MJ
JAMA Netw Open; 2021 Sep; 4(9):e2126447. PubMed ID: 34550382
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
[TBL] [Abstract][Full Text] [Related]
10. Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
Skowronski DM; Kaweski SE; Irvine MA; Kim S; Chuang ESY; Sabaiduc S; Fraser M; Reyes RC; Henry B; Levett PN; Petric M; Krajden M; Sekirov I
CMAJ; 2022 Dec; 194(47):E1599-E1609. PubMed ID: 36507788
[TBL] [Abstract][Full Text] [Related]
11. A Cross-Sectional Study of SARS-CoV-2 Antibodies and Risk Factors for Seropositivity in Staff in Day Care Facilities and Preschools in Denmark.
Fogh K; Eriksen ARR; Larsen TG; Hasselbalch RB; Bundgaard H; Scharff BFSS; Nielsen SD; Jørgensen CS; Erikstrup C; Østergaard L; Ellermann-Eriksen S; Andersen B; Nielsen H; Johansen IS; Wiese L; Hindhede L; Mikkelsen S; Sækmose SG; Aagaard B; Holm DK; Harritshøj L; Simonsen L; Fischer TK; Folke F; Lippert F; Ostrowski SR; Benfield T; Mølbak K; Ethelberg S; Koch A; Vangsted AM; Krause TG; Fomsgaard A; Ullum H; Skov R; Iversen K
Microbiol Spectr; 2023 Feb; 11(1):e0417422. PubMed ID: 36546864
[TBL] [Abstract][Full Text] [Related]
12. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
13. SARS CoV-2 seroprevalence in a US school district during COVID-19.
Bullis SSM; Grebber B; Cook S; Graham NR; Carmolli M; Dickson D; Diehl SA; Kirkpatrick BD; Lee B
BMJ Paediatr Open; 2021; 5(1):e001259. PubMed ID: 34725646
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
[TBL] [Abstract][Full Text] [Related]
15. The COVID-19 Sentinel Schools Network of Catalonia (CSSNC) project: Associated factors to prevalence and incidence of SARS-CoV-2 infection in educational settings during the 2020-2021 academic year.
Ganem F; Bordas A; Folch C; Alonso L; Montoro-Fernandez M; Colom-Cadena A; Mas A; Mendioroz J; Asso L; Anton A; Pumarola T; González MV; Blanco I; Soler-Palacín P; Soriano-Arandes A; Casabona J;
PLoS One; 2022; 17(11):e0277764. PubMed ID: 36395191
[TBL] [Abstract][Full Text] [Related]
16. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
Front Public Health; 2021; 9():689919. PubMed ID: 34222187
[No Abstract] [Full Text] [Related]
17. Evaluation of Test to Stay Strategy on Secondary and Tertiary Transmission of SARS-CoV-2 in K-12 Schools - Lake County, Illinois, August 9-October 29, 2021.
Nemoto N; Dhillon S; Fink S; Holman EJ; Cope AK; Dinh TH; Meadows J; Taryal D; Akindileni F; Franck M; Gelber E; Bacci L; Ahmed S; Thomas ES; Neatherlin JC
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1778-1781. PubMed ID: 34968375
[TBL] [Abstract][Full Text] [Related]
18. Transmission dynamics of SARS-CoV-2 in British Columbia's largest school district during the second half of the 2020-2021 school year.
Campeau L; Thistlethwaite F; Yao JA; Hobbs AJ; Shahriari A; Vijh R; Ng CH; Fung C; Russel S; Zlosnik J; Prystajecky N; Zbar A
Can J Public Health; 2022 Oct; 113(5):653-664. PubMed ID: 35834166
[TBL] [Abstract][Full Text] [Related]
19. Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study.
Snyder T; Ravenhurst J; Cramer EY; Reich NG; Balzer L; Alfandari D; Lover AA
BMJ Open; 2021 Aug; 11(8):e051157. PubMed ID: 34404716
[TBL] [Abstract][Full Text] [Related]
20. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
